Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pharmaxis Ltd ADR (PXSLY)

Pharmaxis Ltd ADR (PXSLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pharmaxis Ltd ADR 20 RODBOROUGH ROAD FRENCHS FOREST C3 2086 AUS

www.pharmaxis.com.au P: 61-2-9454-7200

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Pharmaxis develops innovative pharmaceutical products to treat human respiratory and autoimmune diseases. Its development pipeline of products include AridolTM for asthma, BronchitolTM for cystic fibrosis and chronic obstructive pulmonary disease and PXS64 for multiple sclerosis.

Key Statistics

Overview:

Market Capitalization, $K 26,532
Shares Outstanding, K 30,150
Float, K 30,150
% Float 100.00%
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 8,750 K
Annual Net Income, $ -9,360 K

Growth:

1-Year Return -9.28%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth -82.36%
5-Year Earnings Growth -145.95%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 01/01/70
Earnings Per Share ttm 0.00
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

PXSLY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -106.97%
Debt/Equity 2.82
Price/Sales 3.27
Price/Cash Flow N/A
Price/Book 16.77
Book Value/Share 0.00
Interest Coverage -7.46
60-Month Beta 1.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar